Filed: 2/14/2025ACC: 0001104659-25-014110
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $1.46B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$1.46B
Total AUM (reported)
135.22M
Total Shares
Allocation by class
COM$1.27B86.8%
COM NEW$161.21M11.1%
SPONSORED ADS$9.85M0.7%
CL A ORD SHS$7.63M0.5%
COM SHS$5.58M0.4%
CLASS A ORD SHS$5.06M0.3%
ORD SHS$2.79M0.2%
Portfolio Concentration
Top 3$584.33M40.1%
4–10$442.73M30.4%
11–25$380.65M26.1%
Rest$49.70M3.4%
Top 3 weight
40.1%
Top 10 weight
70.5%
Voting Authority Distribution
Total shares with voting rights: 135.22M
Sole
Full voting authority
135.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$384.75M
26.40%
Sole
8.49M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.76M
TypeSH
Market value$108.99M
7.48%
Sole
12.76M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares4.03M
TypeSH
Market value$90.59M
6.22%
Sole
4.03M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares989.99K
TypeSH
Market value$76.19M
5.23%
Sole
989.99K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$74.43M
5.11%
Sole
3.88M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares3.29M
TypeSH
Market value$63.71M
4.37%
Sole
3.29M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.69M
TypeSH
Market value$62.52M
4.29%
Sole
2.69M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares3.22M
TypeSH
Market value$61.73M
4.24%
Sole
3.22M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.25M
TypeSH
Market value$52.94M
3.63%
Sole
6.25M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$51.22M
3.51%
Sole
2.17M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.68M
TypeSH
Market value$44.34M
3.04%
Sole
5.68M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares16.22M
TypeSH
Market value$40.70M
2.79%
Sole
16.22M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$38.03M
2.61%
Sole
1.74M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.30M
TypeSH
Market value$37.74M
2.59%
Sole
2.30M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.39M
TypeSH
Market value$35.46M
2.43%
Sole
4.39M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares5.05M
TypeSH
Market value$33.56M
2.30%
Sole
5.05M
Shared
0.00
None
0.00
MERUS N V
SOLEShares592.41K
TypeSH
Market value$24.91M
1.71%
Sole
592.41K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares2.46M
TypeSH
Market value$21.97M
1.51%
Sole
2.46M
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares765.72K
TypeSH
Market value$20.58M
1.41%
Sole
765.72K
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$16.81M
1.15%
Sole
1.38M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares2.95M
TypeSH
Market value$16.44M
1.13%
Sole
2.95M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares1.61M
TypeSH
Market value$16.22M
1.11%
Sole
1.61M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares10.26M
TypeSH
Market value$14.67M
1.01%
Sole
10.26M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.35M
TypeSH
Market value$9.85M
0.68%
Sole
1.35M
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares2.63M
TypeSH
Market value$9.36M
0.64%
Sole
2.63M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $384.75M 26.40% | 8.49M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 12.76M | SH | $108.99M 7.48% | 12.76M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 4.03M | SH | $90.59M 6.22% | 4.03M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 989.99K | SH | $76.19M 5.23% | 989.99K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $74.43M 5.11% | 3.88M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 3.29M | SH | $63.71M 4.37% | 3.29M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.69M | SH | $62.52M 4.29% | 2.69M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 3.22M | SH | $61.73M 4.24% | 3.22M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.25M | SH | $52.94M 3.63% | 6.25M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $51.22M 3.51% | 2.17M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 5.68M | SH | $44.34M 3.04% | 5.68M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 16.22M | SH | $40.70M 2.79% | 16.22M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1.74M | SH | $38.03M 2.61% | 1.74M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.30M | SH | $37.74M 2.59% | 2.30M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.39M | SH | $35.46M 2.43% | 4.39M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 5.05M | SH | $33.56M 2.30% | 5.05M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 592.41K | SH | $24.91M 1.71% | 592.41K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 2.46M | SH | $21.97M 1.51% | 2.46M | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 765.72K | SH | $20.58M 1.41% | 765.72K | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $16.81M 1.15% | 1.38M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 2.95M | SH | $16.44M 1.13% | 2.95M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 1.61M | SH | $16.22M 1.11% | 1.61M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 10.26M | SH | $14.67M 1.01% | 10.26M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.35M | SH | $9.85M 0.68% | 1.35M | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 2.63M | SH | $9.36M 0.64% | 2.63M | 0.00 | 0.00 |
Page 1 of 2